JSW Ventures Eyes INR 450 Cr Third Fund, Focus on Tech, Healthcare Startups

An early-stage institutional investor, JSW Ventures backs tech-led startups across healthcare, consumer, enterprise, sustainability, agriculture, and financial services sectors.

JSW Ventures, the venture capital arm of Mumbai-based conglomerate JSW Group, is targeting INR 400-450 Cr for its third investment fund, sources familiar with the development confirmed.

The firm is looking to tap domestic investors for this round, capitalizing on the sharp rise in homegrown venture capital activity in India.

An early-stage institutional investor, JSW Ventures backs tech-led startups across healthcare, consumer, enterprise, sustainability, agriculture, and financial services sectors.

Apart from capital, it offers portfolio companies strategic guidance, operational support, and access to the broader JSW Group ecosystem.

The firm’s INR 300 Cr second fund, launched in 2020, is now fully deployed. Notable investments from that pool include follow-ons in beauty ecommerce platform Purplle and bets on dermatology-focused healthtech startup Cureskin, pet care brand Vetic, and agritech venture Growcoms.

JSW joins a long list of VC firms announcing fresh funds this year as domestic capital dominates India’s venture funding landscape. Accel unveiled a $650 million pool in January, A91 Partners closed its third fund at $665 million, and Capital A and PixelSky Capital announced INR 400 Cr targets for their respective funds.

As per Bain & Company, 95% of India’s VC fundraising activity last year came from domestic players, driven by strong local fundamentals, regulatory reforms, and robust public markets, positioning India as Asia-Pacific’s second-largest VC market.

Stay tuned for more such updates on Digital Health News